| Literature DB >> 33907297 |
Joanna Depciuch1, Edyta Barnaś2, Joanna Skręt-Magierło3, Andrzej Skręt3, Ewa Kaznowska4, Kornelia Łach5, Paweł Jakubczyk6, Jozef Cebulski6.
Abstract
Carcinogenesis is a multifaceted process of cancer formation. The transformation of normal cells into cancerous ones may be difficult to determine at a very early stage. Therefore, methods enabling identification of initial changes caused by cancer require novel approaches. Although physical spectroscopic methods such as FT-Raman and Fourier Transform InfraRed (FTIR) are used to detect chemical changes in cancer tissues, their potential has not been investigated with respect to carcinogenesis. The study aimed to evaluate the usefulness of FT-Raman and FTIR spectroscopy as diagnostic methods of endometrial cancer carcinogenesis. The results indicated development of endometrial cancer was accompanied with chemical changes in nucleic acid, amide I and lipids in Raman spectra. FTIR spectra showed that tissues with development of carcinogenesis were characterized by changes in carbohydrates and amides vibrations. Principal component analysis and hierarchical cluster analysis of Raman spectra demonstrated similarity of tissues with cancer cells and lesions considered precursor of cancer (complex atypical hyperplasia), however they differed from the control samples. Pearson correlation test showed correlation between cancer and complex atypical hyperplasia tissues and between non-cancerous tissue samples. The results of the study indicate that Raman spectroscopy is more effective in assessing the development of carcinogenesis in endometrial cancer than FTIR.Entities:
Year: 2021 PMID: 33907297 PMCID: PMC8079695 DOI: 10.1038/s41598-021-88640-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Raman spectra of samples: control (black spectrum); atrophic endometrium (orange spectrum); complex atypical hyperplasia (red spectrum); endometrial polyp (green spectrum); endometrioid adenocarcinoma (blue spectrum).
Raman shift with corresponding vibrations described in the Raman spectra from Fig. 1[20–24].
| No. | Control | Atrophic endometrium | Atypical complex hyperplasia | Endometrial polyp | Endometrioid adenocarcinoma | Vibrations |
|---|---|---|---|---|---|---|
| 1 | 812 | 806 | Proline, hydroxyproline, tyrosine, PO2− stretching from nucleic acids | |||
| 2 | 890 | 884 | C–C stretching from proline and hydroxyproline | |||
| 3 | 1011 | 1010 | Stretching vibrations of CO, CC, OCH from ring of polysaccharides and pectin | |||
| 4 | 1065 | 1064 | 1064 | 1061 | 1067 | Proline |
| 5 | 1293 | 1296 | 1295 | Amide III (collagen assignment) | ||
| 6 | 1359 | 1358 | Tryptophan | |||
| 7 | 1447 | 1447 | 1446 | 1448 | 1447 | CH2 bending from lipids and proteins |
| 8 | 1553 | 1564 | 1561 | C=C, tryptophan (protein assignment) | ||
| 9 | 1598 | 1599 | C=N and C=C stretching from protein | |||
| 10 | 1695 | Amide I | ||||
| 11 | 1776 | 1763 | C=O stretching from lipids | |||
| 12 | 2798 | 2794 | 2795 | CH3 stretching from lipids | ||
| 13 | 2872 | 2869 | 2872 | 2871 | 2873 | CH2 stretching from lipids |
| 14 | 3087 | OH vibrations from water |
Bold means statistically significant shift.
Figure 2FTIR spectra of samples: control (black spectrum); atrophic endometrium (orange spectrum); complex atypical hyperplasia (red spectrum); endometrial polyp (green spectrum); endometrioid adenocarcinoma (blue spectrum).
FTIR wavenumbers with corresponding vibrations described in the FTIR spectra presented in Fig. 2[25–30].
| No. | Control | Atrophic endometrium | Atypical complex hyperplasia | Endometrial polyp | Endometrioid adenocarcinoma | Vibrations |
|---|---|---|---|---|---|---|
| 1 | 889 | 888 | 889 | 887 | 889 | C–C, C–O deoxyribose,fatty acid, saccharide |
| 2 | 1073 | 1078 | C–O stretching mode of C–OH groups of serine, threonine, and tyrosine of protein | |||
| 3 | * | * | νC–O Carbohydrates | |||
| 4 | 1171 | 1184 | 1169 | ν(C–O), ν(C–C), def. C–O–H (proteins, glycogen, carbohydrates) | ||
| 5 | 1240 | 1241 | Amide III (N–H bending, C–N stretch, C–C stretch) (proteins, DNA, phospholipids) | |||
| 6 | 1280 | * | * | * | Deformation N–H cytosine | |
| 7 | 1341 | 1341 | 1341 | 1340 | CH2 wagging for proline (amino acids and collagen) | |
| 8 | 1466 | 1466 | 1465 | CH2 group scissoring modes | ||
| 9 | 1544 | Amide II due to N–H bending and C–N stretching of proteins | ||||
| 10 | 1642 | 1642 | Amide I (ν(C=O), ν(CN), γ(CCN), δ(NH)) (proteins) | |||
| 11 | 2847 | 2847 | 2848 | Symmetric stretching of the CH2 group due to mainly lipids, with little contribution from proteins, carbohydrates and nucleic acids | ||
| 12 | 2915 | 2915 | 2915 | 2915 | CH2 asymmetric stretch: mainly lipids, with little contribution from proteins, carbohydrates, nucleic acids | |
| 13 | 2957 | 2956 | 2957 | 2956 | CH3 asymmetric stretch: mainly lipids |
Bold means statistically significant shift.
Figure 3Mean ± standard error of the mean (SEM) intensity values of the individual peaks measured with Raman (a) and FTIR (b) for all groups of tissue samples, where color bars stand for: control (black spectrum); atrophic endometrium (orange spectrum); complex atypical hyperplasia (red spectrum); endometrial polyp (green spectrum); endometrioid adenocarcinoma (blue spectrum). Data was analyzed using one-way ANOVA followed by Tukey's post hoc test. Statistical significance was adopted at *p < 0.05 versus Control; ^ p < 0.05 versus atrophic endometrium; & p < 0.05 versus complex atypical hyperplasia; # p < 0.05 versus endometrial polyp; + p < 0.05 versus endometrioid adenocarcinoma.
Figure 4PCA (a, c, e, f) and HCA (b, d) analysis of: control (black dot); atrophic endometrium (orange dot); complex atypical hyperplasia (red dot); endometrial polyp (green dot); endometrioid adenocarcinoma (blue dot) Raman (a, b, e) and FTIR (c, d, f) spectra. Two-dimensional (2D) scores plot of samples with differences in chemical compositions presented through the selected spectral regions: all spectral region for Raman spectra and points corresponding to C–O stretching mode of C–OH groups of serine, threonine, and tyrosine of protein and νC–O vibration from carbohydrates for FTIR data. The results for average spectra were shown in Figure (a–d) and for all analyzed samples—e, f with marker with vectors of least-squared lines representing the various groups.
Figure 5Plots of predicted for Raman (a) and FTIR (d) region, which could be used to separate endometrial tissues with different carcinogenesis stages. Normal Probability Plot of residual collected from predicted plots for Raman (b) and FTIR (e) spectra. VIP values plot for the all analyzed Raman (c) and FTIR (f) range with 0.8 VIP thresholds, where colors stands for the following samples: control (black); atrophic endometrium (orange); complex atypical hyperplasia (red); endometrial polyp (green); endometrioid adenocarcinoma (blue).
Percentage accuracy with error value of selected and for fingerprint region (800–1800 cm−1) for obtained Raman and FTIR spectra.
| Random forest | C5.0 | |||
|---|---|---|---|---|
| Accuracy (%) | Error (%) | Accuracy (%) | Error (%) | |
| Raman selected | 92.73 | 7.27 | 76.36 | 23.64 |
| Raman fingerprint | 92.73 | 7.27 | 83.64 | 16.36 |
| FTIR selected | 96.61 | 3.39 | 62.71 | 37.29 |
| FTIR fingerprint | 96.61 | 3.39 | 84.75 | 15.25 |
Pearson correlation (p < 0.05) test for Raman and FTIR spectra.
| Control | Atrophic endometrium | Atypical hyperplasia | Endometrial polyp | Endometrioid adenocarcinoma | |
|---|---|---|---|---|---|
| Control | 0.80* | 0.86* | |||
| Atrophic endometrium | 0.80* | 0.75* | |||
| Atypical hyperplasia | 0.95* | ||||
| Endometrial polyp | 0.86* | 0.97* | 0.95* | ||
| Endometrioid adenocarcinoma | 0.93* | 0.97* | 0.93* | ||
| Control | 0.95* | 0.93* | 0.95* | 0.98* | |
| Atrophic endometrium | 0.95* | 0.97* | 0.84* | 0.98* | |
| Atypical hyperplasia | 0.93* | 0.97* | 0.81* | 0.96* | |
| Endometrial polyp | 0.95* | 0.84* | 0.81* | 0.90* | |
| Endometrioid adenocarcinoma | 0.98* | 0.98* | 0.96* | 0.90* | |
*Statistically significant, when p < 0.05.